09.05.2023 10:35:00
|
Major shareholder announcement
Company announcement
Orphazyme A/S
No. 04/2023
Ole Maaløes Vej 3
DK-2200 Copenhagen N
www.orphazyme.com
Company Registration No. 32266355
Copenhagen, Denmark, May 9, 2023 – Orphazyme A/S (ORPHA.CO) (the "Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from MH Investment ApS, that as of May 8, 2023, MH Investment ApS holds shares, corresponding to more than 5% of the total share capital and voting rights in the Company.
For additional information, please contact
Orphazyme A/S
Anders Vadsholt, Chief Executive Officer and Chief Financial Officer: +45 28 98 90 55
Attachment
![](https://ml-eu.globenewswire.com/media/Y2QyZTc0YjYtN2M2Yy00ZGI3LTk4ZTctODFjOGY1ZTY4MjEwLTExMDI3NjI=/tiny/ORPHAZYME-A-S.png)
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Orphazyme A-S Bearer and-or registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |